Literature DB >> 22014321

Characteristics of recurrent musculoskeletal pain in children with cerebral palsy aged 8 to 18 years.

Kjersti Ramstad1, Reidun Jahnsen, Ola H Skjeldal, Trond H Diseth.   

Abstract

AIM: The aim of this study was to explore the prevalence, predictors, severity, and impact of recurrent musculoskeletal pain in children and adolescents with cerebral palsy (CP).
METHOD: One hundred and fifty-three participants (81 males, 72 females) aged 8 to 18 years were assessed by clinical examination, interview, and questionnaires. CP type distribution was 38% unilateral spastic, 55% bilateral spastic, 6% dyskinetic, and 1% ataxic. Gross Motor Function Classification System (GMFCS) levels were as follows: level I, 54; level II, 56; level III, 20; level IV, 8; and level V, 15. Sixty-four children and 89 parents recorded pain on the Child Health Questionnaire, 56 children and 85 parents indicated impact of pain on 0 to 10 numeric rating scales, and 72 children indicated pain intensity on the Faces Pain Scale-Revised.
RESULTS: Ninety-five (62%) children across all GMFCS levels experienced recurrent musculoskeletal pain. Age above 14 years was the only significant predictor (OR 2.90, 95% CI 1.22-7.80, p=0.02, adjusted for sex, CP type, gross motor function and mother's education). Children reported recurrent musculoskeletal pain to be moderate. Parents reported pain to be more severe and with higher impact on sleep than their children did. Children and parents reported similar impact of pain on general activity and walking.
INTERPRETATION: Recurrent musculoskeletal pain is the dominating pain problem in children and adolescents with CP. Monitoring of musculoskeletal pain should be part of the medical follow-up across the whole range of motor impairment. © The Authors. Developmental Medicine & Child Neurology
© 2011 Mac Keith Press.

Entities:  

Mesh:

Year:  2011        PMID: 22014321     DOI: 10.1111/j.1469-8749.2011.04070.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  31 in total

1.  Pain experience and expression in Rett syndrome: Subjective and objective measurement approaches.

Authors:  Chantel C Barney; Timothy Feyma; Arthur Beisang; Frank J Symons
Journal:  J Dev Phys Disabil       Date:  2015-03-01

2.  Effectiveness of Multilevel Botulinum Toxin A Injection with Integrated Treatment Program on Spasticity Reduction in Non-Ambulatory Young Children with Cerebral Palsy.

Authors:  Sebahat Aydil; Fatma Merih Akpinar; Evren Akpinar; Kubilay Beng; Mehmet Firat Yagmurlu
Journal:  Med Princ Pract       Date:  2019-03-06       Impact factor: 1.927

3.  A case-controlled comparison of postoperative analgesic dosing between girls with Rett syndrome and girls with and without developmental disability undergoing spinal fusion surgery.

Authors:  Chantel C Barney; Alyssa M Merbler; Kelsey Quest; Breanne J Byiers; George L Wilcox; Scott Schwantes; Samuel A Roiko; Timothy Feyma; Arthur Beisang; Frank J Symons
Journal:  Paediatr Anaesth       Date:  2017-02-08       Impact factor: 2.556

Review 4.  [Challenges in pain assessment and management among individuals with intellectual and developmental disabilities : German version].

Authors:  Chantel C Barney; Randi D Andersen; Ruth Defrin; Lara M Genik; Brian E McGuire; Frank J Symons
Journal:  Schmerz       Date:  2021-09-13       Impact factor: 1.107

5.  Motor function predicts parent-reported musculoskeletal pain in children with cerebral palsy.

Authors:  Chantel C Barney; Linda E Krach; Patrick F Rivard; John L Belew; Frank J Symons
Journal:  Pain Res Manag       Date:  2013 Nov-Dec       Impact factor: 3.037

6.  Factors that Predict Overall Health and Quality of Life in Non-Ambulatory Individuals with Cerebral Palsy.

Authors:  Samuel E Kolman; Allan M Glanzman; Laura Prosser; David A Spiegel; Keith D Baldwin
Journal:  Iowa Orthop J       Date:  2018

7.  Updates in the treatment of spasticity associated with cerebral palsy.

Authors:  Ruba Benini; Michael I Shevell
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

Review 8.  Oral Muscle Relaxants for the Treatment of Chronic Pain Associated with Cerebral Palsy.

Authors:  Jacki Peck; Ivan Urits; Joshua Crane; Alexandra McNally; Nazir Noor; Megha Patel; Amnon A Berger; Elyse M Cornett; Hisham Kassem; Alan D Kaye; Omar Viswanath
Journal:  Psychopharmacol Bull       Date:  2020-10-15

9.  Evaluation of the effects of botulinum toxin A injections when used to improve ease of care and comfort in children with cerebral palsy whom are non-ambulant: a double blind randomized controlled trial.

Authors:  Megan Thorley; Samantha Donaghey; Priya Edwards; Lisa Copeland; Megan Kentish; Kim McLennan; Jayne Lindsley; Laura Gascoigne-Pees; Leanne Sakzewski; Roslyn N Boyd
Journal:  BMC Pediatr       Date:  2012-08-09       Impact factor: 2.125

10.  Pain in young people aged 13 to 17 years with cerebral palsy: cross-sectional, multicentre European study.

Authors:  Kathryn N Parkinson; Heather O Dickinson; Catherine Arnaud; Alan Lyons; Allan Colver
Journal:  Arch Dis Child       Date:  2013-04-20       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.